Suppr超能文献

系统评价:SeHCAT 扫描诊断腹泻型肠易激综合征患者特发性胆汁酸吸收不良的患病率。

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

机构信息

Department of Nutrition & Dietetics, The Royal Marsden Hospital, London and Sutton, UK.

出版信息

Aliment Pharmacol Ther. 2009 Oct;30(7):707-17. doi: 10.1111/j.1365-2036.2009.04081.x. Epub 2009 Jun 30.

Abstract

BACKGROUND

Recurrent, watery diarrhoea affects one-third of patients diagnosed with irritable bowel syndrome ('IBS-D'). Idiopathic bile acid malabsorption ('I-BAM') may be the cause.

AIM

To determine the prevalence of I-BAM in patients suffering from IBS-D.

METHODS

A systematic search was performed of publications reporting patients presenting with IBS-D type symptoms, who were subsequently confirmed as having I-BAM by SeHCAT scanning.

RESULTS

Eighteen relevant studies, 15 prospective, comprising 1223 patients were identified. Five studies (429 patients) indicated that 10% (CI: 7-13) patients had severe bile acid malabsorption (SeHCAT 7 day retention <5% of baseline value). 17 studies (1073 patients) indicated that 32% (CI: 29-35) patients had moderate bile acid malabsorption (SeHCAT <10%). 7 studies (618 patients) indicated that 26% (CI: 23-30) patients had mild (SeHCAT <15%) bile acid malabsorption. Pooled data from 15 studies showed a dose-response relationship according to severity of malabsorption to treatment with a bile acid binder: response to colestyramine occurred in 96% of patients with <5% retention, 80% at <10% retention and 70% at <15% retention.

CONCLUSIONS

Idiopathic adult-onset bile acid malabsorption is not rare. International guidelines for the management of irritable bowel syndrome need to be revised so that clinicians become more aware of this possibility.

摘要

背景

复发性水样腹泻影响三分之一被诊断为肠易激综合征(“IBS-D”)的患者。特发性胆汁酸吸收不良(“I-BAM”)可能是其病因。

目的

确定 IBS-D 患者中 I-BAM 的患病率。

方法

系统检索报告 IBS-D 型症状患者的文献,这些患者随后通过 SeHCAT 扫描被证实为 I-BAM。

结果

确定了 18 项相关研究,其中 15 项为前瞻性研究,共纳入 1223 例患者。5 项研究(429 例患者)表明,10%(95%CI:7-13)的患者存在严重胆汁酸吸收不良(7 天 SeHCAT 保留率<5%基线值)。17 项研究(1073 例患者)表明,32%(95%CI:29-35)的患者存在中度胆汁酸吸收不良(SeHCAT<10%)。7 项研究(618 例患者)表明,26%(95%CI:23-30)的患者存在轻度(SeHCAT<15%)胆汁酸吸收不良。15 项研究的汇总数据显示,根据吸收不良的严重程度与胆汁酸结合剂治疗的反应呈剂量反应关系:<5%保留率的患者对考来烯胺的反应率为 96%,<10%保留率的患者为 80%,<15%保留率的患者为 70%。

结论

特发性成人胆汁酸吸收不良并不罕见。国际肠易激综合征管理指南需要修订,以使临床医生更加意识到这种可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验